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Research Article

Antimicrobial susceptibility differences among mucoid
and non-mucoid Pseudomonas aeruginosa isolates
Unterschiede in der antimikrobiellen Empfindlichkeit nicht Mukoid und
Mukoid bildender Pseudomonas aeruginosa-Isolate
Abstract
Pseudomonas aeruginosa is one of the most important opportunistic
bacteria, causing a wide variety of infections particularly in immunocompromised patients. The extracellular glycocalyx is produced in copious
amounts by mucoid strains of P. aeruginosa. Mucoid and non-mucoid
P. aeruginosa strains show some differences in their antimicrobial
susceptibility pattern. The aim of this study was to investigate the frequency of mucoid and non-mucoid types and their antimicrobial susceptibility patterns isolated from Milad and Mostafa Khomeini Hospital
in Tehran, Iran.
One hundred P. aeruginosa isolates were collected which all were confirmed by conventional biochemical tests and PCR assay using specific
primers for oprI and oprL lipoproteins. Mucoid and non-mucoid types
of isolates were determined by culturing isolates on BHI agar containing
Congo red and Muir mordant staining method. The susceptibility pattern
of isolates against 23 different antibiotics was assessed using MIC
sensititre susceptibility plates.
Fifty of 100 of isolates were mucoid type, of which 14 isolates were
from Mostafa Khomeini Hospital. Frequency of mucoid type of P. aeruginosa in Mostafa Khomeini hospital (70%) was higher than that seen
in Milad hospital (45%). The statistical analysis of MICs results showed
significant differences in antimicrobial resistance among mucoid and
non-mucoid types (non mucoid strains showed more resistance against
tested antibiotics). This may be due to the tendency of some antibiotics
to attach to extracellular glycocalyx of mucoid strains.
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Zusammenfassung
Pseudomonas aeruginosa ist eines der wichtigsten opportunistischen
Bakterien, das vor allem bei immunsupprimierten Patienten eine Vielzahl
von Infektionen verursacht. Die extrazelluläre Glycocalyx wird von Mukoid bildenden P. aeruginosa-Stämmen in großer Menge gebildet. Mukoid und nicht Mukoid bildende P. aeruginosa-Stämme zeigen einige
Unterschiede in ihrer antimikrobiellen Empfindlichkeit. Daher sollte die
Häufigkeit Mukoid und nicht Mukoid bildender Isolate und deren antimikrobielle Empfindlichkeit im Milad und Mostafa Khomeini Hospital
in Teheran, Iran, analysiert werden.
Es wurden 100 P. aeruginosa-Isolate gesammelt und biochemisch sowie
mittels PCR (spezifische Primer für oprI und oprL Lipoproteine) bestätigt.
Mukoid und nicht Mukoid bildende Isolate wurden durch Kultivierung
auf BHI-Agar mit Kongorot und Färbung nach Muir bestimmt. Die MIC
wurde gegen 23 Antibiotika ermittelt.
50 der 100 Isolate bildeten Mukoid, davon 14 aus dem Mostafa Khomeini Hospital. Die Häufigkeit der Mukoid-Bildner war im Mostafa
Khomeini Hospital mit 70% höher als im Milad Hospital (45%). Die nicht
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Mukoid bildenden Isolate erwiesen sich als signifikant resistenter gegen
die getesteten Antibiotika. Eine Ursache hierfür könnte die Tendenz
mancher Antibiotika zum Attachment an die extrazelluläre Glycocalyx
Mukoid bildender Stämme sein.
Schlüsselwörter: Pseudomonas aeruginosa, Mukoid/nicht Mukoid,
antimikrobielle Empfindlichkeit

Introduction
Pseudomonas aeruginosa is one of the most common
pathogens causing nosocomial infection with the high
mortality rate [1], [2], [3]. The intrinsic resistance of
P. aeruginosa to numerous antimicrobial agents and
notable increasing of multi-drug resistance strains play
an important role in high mortality rate in nosocomial infection [4], [5]. Moreover, it was shown that P. aeruginosa
is an important pathogen causing severe infections in
patients suffering from respiratory diseases, chemotherapy cancer patients, immunocompromised hosts and
young adults with cystic fibrosis [6], [7], [8], [9]. P. aeruginosa is a highly adaptable microorganism and can develop resistance to different antibiotics. Multidrug-resistance (MDR) strains of P. aeruginosa use different mechanisms for developing resistance such as producing enzymes for inactivating β-lactams like ESBL (extended
spectrum beta lactamase), MBL (metallo-β-lactamase)
[10], [11], and biofilm formation can enhance ability of
resistance in P. aeruginosa [12]. P. aeruginosa isolated
from respiratory tract with typical non-mucoid phenotype,
but in prolonged infection, can shift to mucoid form with
producing large amounts of exopolysaccharide called alginate [13], [14]. Overexpression of alginate in mucoid
strains forming micro-colonies which may be less susceptible to host defense mechanisms [15]. Mutation may induce mucoid variants, emerging within months of colonization. Thus, transition from early colonization to chronic
infection may be associated with a change in P. aeruginosa phenotype from non-mucoid to mucoid colony
formation [16]. The antimicrobial susceptibility pattern
is different between mucoid and non-mucoid P. aeruginosa strains. It was suggested that biofilm formation
of P. aeruginosa strains are more resistant to antibiotics;
initially this resistance was related to mucoid strains. One
hypothesis has been that glycocalyx can act like a major
barrier to antibiotic diffusion because of its polyanionic
characteristics [17], [18]. This hypothesis was refuted by
the fact that some antibiotics such as tobramycin can
bind to exopolysaccharide produced by P. aeruginosa
[19].
The aim of this study was to determine the phenotypic
type (mucoid/non-mucoid) of P. aeruginosa isolated from
hospitalized patients in Milad and Mostafa Khomeini
Hospitals in Tehran, Iran and to investigate the differences in antimicrobial susceptibility pattern among
mucoid and non-mucoid isolates.

Materials and methods
One hundred P. aeruginosa were collected from two
hospitals in Tehran. Eighty P. aeruginosa were isolated
from hospitalized patients in Milad Hospital and
20 strains from patients referred to Mostafa Khomeini
Hospital.

Biochemical and molecular identification
of bacterial strains
Initial biochemical tests were performed to characterize
P. aeruginosa such as growth on MacConkey agar medium, oxidase, catalase, urease, Sulfur Indole Motility test
(SIM), triple sugar iron agar, oxidation/fermentation
glucose, lysine decarboxylase, methyl red and VogesProskauer (MR-VP), Simmon citrate test, gelatin hydrolysis
and growth at 42°C. The identity of isolates was confirmed using two specific sets of primers which amplify
two outer membrane lipoproteins as described elsewhere
[20]. PCR amplification of I lipoprotein (oprl) was performed for detection of genus and L lipoprotein (oprL) for
detection of species of this organism. The sequences of
primers are shown in Table 1. Bacterial DNA extraction
was performed using boiling method and extracts of genomic DNA were subjected to PCR assay. PCR was performed in a reaction mixture with the total volume of 25 Il,
containing 5 Il template DNA (20 ng), 2.5 Il 10X Taq
polymerase buffer [100 mM Tris/HCl (pH 8.3), 500 mM
KCl, and 15 mM MgCl2], 0.25 Il (100 pmol/ Il) each of
primers, 0.25 Il dNTPs (10 mM), 0.2 Il (5U/ Il) Taq DNA
polymerase and 16.55 Il sterilized distilled water. Amplification for oprI and oprL was done as follows: initial denaturation step at 93°C for 5 min followed by 30 cycles
consisting of denaturation (93°C for 1 min), annealing
(57°C for 1 min), and extension (72°C for 1 min), followed by a final extension step at 72°C for 10 min.

Differentiation of mucoid and
non-mucoid strains
Mucoid strains were identified using the Muir method as
described elsewhere [21]. Briefly, for each of 100 isolates,
a thin film of suspension was prepared and air-dried, the
film was covered with a piece of filter paper and slide was
flooded with Ziehl-Neelsen carbol fuchsin and heated to
steaming for 30 seconds. The slide was gently rinsed with
95% ethanol and then with distilled water. Mordant
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Table 1: Primer sequences

solution was added for 20 seconds and then washed with
distilled water followed by de-colorization step using
ethanol. For counterstaining, 0.3% methylene blue was
used for 30–60 seconds prior to examination of the preparations under the oil immersion lens. The cells were
stained red, and the capsules blue.

Determination of biofilm formation by
Congo red agar method (CRA)
Biofilm formation was determined by the CRA method
described elsewhere [22]. BHI agar medium was prepared
and supplemented with 5% sucrose and 0.08% Congo
red (Sigma-Aldrich, Germany). Congo red was prepared
in form of concentrated aqueous solution and it was
autoclaved at 121°C for 15 min, separately from other
medium constituents. Following autoclave, the concentrated solution was added to agar which was previously
cooled to 55°C. All 100 isolates were cultivated in streaks
on prepared BHI agar medium and incubated aerobically
at 37°C for 24–48 h.

Minimum inhibitory concentration (MIC)
Minimum inhibitory concentration (MIC) for 23 different
antibiotics was performed for all 100 isolates using MIC
sensititre susceptibility plates (TREK Diagnostic Systems,
Cleveland, OH) according to instruction provided by the
manufacturer. The bacterial suspension of isolates with
final concentration of 105 CFU/ml was prepared and
followed by manufacturer’s instruction.

Statistical analysis
The MICs of all tested antibiotics for mucoid and nonmucoid isolates were analyzed using SPSS software,
version 17.0. The chi square of all antibiotics was determined between mucoid and non-mucoid isolates and
p-value of less than 0.05 was considered significant.

Results
Identification of isolates

confirmed the identification of isolates. Specific 249 and
504 bp bands were detected in all isolates which were
corresponded to oprI and oprL gene and determine the
Pseudomonas genus and P. aeruginosa, respectively
(Figure 1).

Differentiation between mucoid and
non-mucoid isolates
Phenotypic determination of mucoid and non-mucoid
isolates was investigated by two phenotypic method, Muir
mordant staining and Congo red agar assay. Half of the
isolates (50%) were mucoid and 50% were non-mucoid.
The mucoid strains showed red colonies and non-mucoid
produced pink to white colonies on BHI agar containing
Congo red and sucrose. Fourteen of 20 (70%) strains
isolated from Mostafa Khomeini Hospital and 36 of 80
(45%) strains isolated from Milad Hospital were mucoid.

Antimicrobial susceptibility among
mucoid and non-mucoid isolates
Antimicrobial susceptibility pattern of mucoid and nonmucoid P. aeruginosa against 23 different tested antibiotics was determined (Table 2). Among mucoid isolates,
high resistance corresponded to sulfisoxazole (100%),
chloramphenicol (100%), co-trimoxazole (98%), tetracycline (98%) and ampicillin/sulbactam (96%). Whereas high
resistance rate among non-mucoid isolates was seen in
sulfisoxazole (100%), ampicillin/sulbactam (100%), cotrimoxazole (92%), cefotaxime (84%), chloramphenicol
(98%), ceftriaxone (82%) and tetracycline (98%).

Statistical analysis of susceptibility
patterns of mucoid and non-mucoid
isolates
Statistical analysis showed that non-mucoid isolates were
significantly more resistant than mucoid type to β-lactams,
aminoglycosides (such as amikacin, tobramycin and
gentamicin) and quinolones (i.e., levofloxacin, ciprofloxacin, levofloxacin) (p<0.05). While no significant difference
was observed among mucoid and non-mucoid strains in
resistance to other tested antibiotics (p>0.05).

One hundred isolates with yellow colonies on MacConkey
agar medium, lactose –, oxidase +, Simmon citrate +,
urease –, TSI (Alk/Alk), lysine decarboxylase –, oxidation
of glucose +, MR –, VP –, gelatin hydrolysis + and growth
on 42°C + were identified as P. aeruginosa. PCR assay
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Figure 1: A) PCR amplification of oprI gene among suspected isolates for detection of Pseudomonas spp. M: 1kb DNA size
marker; lane1: positive control P. aeruginosa ATCC 27853; lane; 2,3: suspected isolates.
B) PCR amplification of oprL gene among suspected isolates for detection of P. aeruginosa. M: 1kb DNA size marker; lane1:
positive control P. aeruginosa ATCC 27853; lane; 2–3 suspected isolates.
Table 2: Susceptibility pattern of P. aeruginosa isolate to different antibiotics (Number of strains (%))
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Discussion
P. aeruginosa infection is a serious cause of nosocomial
infection. This organism is adapted by forming biofilms
in which the bacteria are protected from host defenses
and antibiotics [23]. For instance, biofilm formation of
mucoid P. aeruginosa strains is the main cause of lung
infections in patients with cystic fibrosis. The results of
this study indicated that amount of mucoid strains have
been increased recently in Iran in contrast to previous
studies [24]. According to previous studies it was thought
that antimicrobial susceptibility patterns are different
between mucoid and non-mucoid P. aeruginosa strains
[6], [25], [26]. The results of this study showed that
mucoid isolates were more susceptible to antibiotics
which is consistent with findings of other studies from
United States, Thailand [6], [26], [27].
One hypothesis suggests that the glycocalyx material itself
usually acts as a polyanionic polysaccharide barrier to
antibiotic diffusion [17], [18]. This was refuted by the fact
that, although some antibiotics such as tobramycin binds
to the exopolysaccharide produced by P. aeruginosa, the
resulting reduction in diffusion coefficient of tobramycin
within a colony or biofilm would not be enough to allow
one to define the glycocalyx as a significant penetration
barrier [28]. In the present study, 50% of P. aeruginosa
isolates were identified as mucoid type. These findings
showed the significant increase in mucoid form of
P. aeruginosa in comparison with other studies in Iran
(32%) and Thailand (3.6%) [6], [24]. The differences
between antimicrobial susceptibility pattern among
mucoid and non-mucoid types were more significant in
β-lactams antibiotics (i.e. ceftazidime, piperacillin, cefoperazone, ticarcillin, cefepime and carbenicillin (p<0.05).
However, in other β-lactams (i.e., cefotaxime, ceftriaxone,
aztreonam and imipenem) no significant differences were
observed. The higher resistance to β-lactams among nonmucoid strains seen in this study is consistent with Ciofu
et al. [29]. In Ciofu study, it was reported that non-mucoid
isolates have more ability to produce β-lactamase and
are exposed to a relatively higher antibiotic selective
pressure than the mucoid type. This might be due to
biofilm formation. The biofilm-embedded cells may have
different antimicrobial susceptibility pattern depending
on the site where each individual bacterial cell is located
within the multiple layer of biofilm [30]. The β-lactamase
produced by the superficial layer in the biofilm and will
be able to inactive the β-lactam before reaching into the
deep layers [31]. Mucoid and non-mucoid phenotypes
can live in symbiosis within the biofilm. While the mucoid,
alginate hyper-producing cells ensure the survival of the
biofim, the non-mucoid cells might play protective role
against antibiotics.
Resistance to quinolones and aminoglycosides was significant higher in non-mucoid P. aeruginosa isolates than
mucoid types. There was no significant difference in resistance to tetracycline, chloramphenicol and cotrimoxazole among mucoid and non-mucoid isolates.

In summary, our findings show the mucoid isolates were
generally more susceptible to antibiotics than non-mucoid
P. aeruginosa. Regarding the importance of mucoid isolates in nosocomial infections among hospitalized patients
specially patients with cystic fibrosis, differentiation
between mucoid and non-mucoid isolates may play a
major role in the prevention of nosocomial infections. The
antimicrobial susceptibility pattern was significantly different between mucoid and non-mucoid P. aeruginosa
isolates; these findings could enhance accurate diagnosis
and proper antibiotic treatment in nosocomial infection
cases. On the other hand, different antibiotic resistance
patterns observed in this study could be association with
different origin of these isolates which would require further investigation.
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